PHBI (Pharmagreen Biotech) Interest Expense: $-0.10 Mil (TTM As of Jun. 2023)


What is Pharmagreen Biotech Interest Expense?

Pharmagreen Biotech PHBI Interest Expense is $-0.10 Mil as of Jun. 2023.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Pharmagreen Biotech's interest expense for the three months ended in Jun. 2023 was $ -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.10 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Pharmagreen Biotech's Operating Income for the three months ended in Jun. 2023 was $ -0.08 Mil. Pharmagreen Biotech's Interest Expense for the three months ended in Jun. 2023 was $ -0.02 Mil. Pharmagreen Biotech did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pharmagreen Biotech  (OTCPK:PHBI) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pharmagreen Biotech's Interest Expense for the three months ended in Jun. 2023 was $-0.02 Mil. Its Operating Income for the three months ended in Jun. 2023 was $-0.08 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2023 was $0.12 Mil.

Pharmagreen Biotech's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

Pharmagreen Biotech did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Pharmagreen Biotech Interest Expense Historical Data

* Premium members only.

The historical data trend for Pharmagreen Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagreen Biotech Interest Expense Chart

Pharmagreen Biotech Annual Data
Trend Apr08 Apr09 Sep18 Sep19 Sep20 Sep21 Sep22
Interest Expense
Get a 7-Day Free Trial -0.00 -0.01 -0.67 -0.77 -0.05

Pharmagreen Biotech Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.01 -0.02 -0.05 -0.02

Pharmagreen Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.10 Mil mean?
Pharmagreen Biotech (PHBI) has a Interest Expense of $-0.10 Mil as of Jun. 2023. Interest Expense is the amount a company pays on its long-term debt. View historical data on Pharmagreen Biotech and its competitors.
Is Pharmagreen Biotech's Interest Expense too high?
Pharmagreen Biotech's current Interest Expense is $-0.10 Mil.
How does Pharmagreen Biotech's Interest Expense compare to DVLP and CSTF?
Pharmagreen Biotech's Interest Expense of $-0.10 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Pharmagreen Biotech and its competitors. Pharmagreen Biotech's current Interest Expense is $-0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagreen Biotech stock overvalued right now?
Pharmagreen Biotech (PHBI) has a current Interest Expense of $-0.10 Mil. The current Interest Expense is $-0.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Pharmagreen Biotech (PHBI), the current Interest Expense is $-0.10 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagreen Biotech Business Description

Address 112 North Curry Street, Carson, NV, USA, 89703
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.